Beta Drugs Ltd. - Research Center
Results
|
Annual
|
Statement
|
|
More
|
|
Annual results in brief
(Rs crore)
|
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Sales |
197.62 |
157.87 |
124.85 |
79.46 |
65.32 |
Operating profit |
33.53 |
31.20 |
25.18 |
15.31 |
11.75 |
Interest |
1.05 |
0.84 |
0.41 |
0.77 |
0.64 |
Gross profit |
34.21 |
31.40 |
25.63 |
15.15 |
11.53 |
EPS (Rs) |
22.82 |
19.57 |
14.82 |
7.26 |
7.39 |
Annual
results in details
|
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Other income |
1.73 |
1.04 |
0.86 |
0.61 |
0.42 |
Stock adjustment |
-6.97 |
-3.17 |
0.86 |
-1.38 |
0.20 |
Raw material |
119.27 |
86.47 |
69.86 |
44.83 |
34.61 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
14.32 |
13.42 |
8.72 |
6.06 |
4.93 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
37.48 |
29.96 |
20.21 |
14.64 |
13.82 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
4.72 |
6.19 |
5.47 |
5.27 |
2.58 |
Taxation |
7.55 |
6.39 |
5.92 |
2.90 |
1.85 |
Net profit / loss |
21.94 |
18.82 |
14.25 |
6.98 |
7.10 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
9.61 |
9.61 |
9.61 |
9.61 |
9.61 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
16.96 |
19.76 |
20.17 |
19.27 |
17.99 |
GPM (%) |
17.16 |
19.76 |
20.39 |
18.92 |
17.54 |
NPM (%) |
11.00 |
11.84 |
11.33 |
8.71 |
10.80 |